1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 295:2483–2491. 2006.
Article
2. Barnett GH, Linskey ME, Adler JR, Cozzens JW, Friedman WA, Heilbrun MP, et al. Stereotactic radiosurgery--an organized neurosurgerysanctioned definition. J Neurosurg. 106:1–5. 2007.
Article
3. Coffey RJ. Boost gamma knife radiosurgery in the treatment of primary glial tumors. Stereotact Funct Neurosurg 61 Suppl. 1:59–64. 1993.
Article
4. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1341–1346. 1995.
Article
5. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009.
Article
6. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol. 81:18–24. 2006.
Article
7. Friedman WA, Foote KD. Linear accelerator radiosurgery in the management of brain tumours. Ann Med. 32:64–80. 2000.
Article
8. Fuss M, Salter BJ, Cheek D, Sadeghi A, Hevezi JM, Herman TS. Repositioning accuracy of a commercially available thermoplastic mask system. Radiother Oncol. 71:339–345. 2004.
Article
9. Jeong WJ, Park JH, Lee EJ, Kim JH, Kim CJ, Cho YH. Efficacy and safety of fractionated stereotactic radiosurgery for large brain metastases. J Korean Neurosurg Soc. 58:217–224. 2015.
Article
10. Jin JY, Ryu S, Faber K, Mikkelsen T, Chen Q, Li S, et al. 2D/3D image fusion for accurate target localization and evaluation of a mask based stereotactic system in fractionated stereotactic radiotherapy of cranial lesions. Med Phys. 33:4557–4566. 2006.
Article
11. Kondziolka D, Lunsford LD, Loeffler JS, Friedman WA. Radiosurgery and radiotherapy: observations and clarifications. J Neurosurg. 101:585–589. 2004.
Article
12. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 76(3 Suppl):S20–S27. 2010.
Article
13. Leksell L. Cerebral radiosurgery. I. Gammathalanotomy in two cases of intractable pain. Acta Chir Scand. 134:585–595. 1968.
14. Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry. 46:797–803. 1983.
Article
15. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta chir scand. 102:316–319. 1951.
16. Lutz W, Winston KR, Maleki N. A system for stereotactic radiosurgery with a linear accelerator. Int J Radiat Oncol Biol Phys. 14:373–381. 1988.
Article
17. Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 76(3 Suppl):S28–S35. 2010.
Article
18. Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys. 76(3 Suppl):S36–S41. 2010.
Article
19. Minniti G, D’Angelillo RM, Scaringi C, Trodella LE, Clarke E, Matteucci P, et al. Fractionated stereotactic radiosurgery for patients with brain metastases. J Neurooncol. 117:295–301. 2014.
Article
20. Minniti G, Scaringi C, Paolini S, Lanzetta G, Romano A, Cicone F, et al. Single-fraction versus multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis. Int J Radiat Oncol Biol Phys. 95:1142–1148. 2016.
Article
21. Murai T, Ogino H, Manabe Y, Iwabuchi M, Okumura T, Matsushita Y, et al. Fractionated stereotactic radiotherapy using Cyberknife for the treatment of large brain metastases: a dose escalation study. Clin Oncol (R Coll Radiol). 26:151–158. 2014.
Article
22. Ogura K, Mizowaki T, Ogura M, Sakanaka K, Arakawa Y, Miyamoto S, et al. Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors. J Neurooncol. 109:425–432. 2012.
Article
23. Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys. 51:426–434. 2001.
Article
24. Solberg TD, Medin PM, Mullins J, Li S. Quality assurance of immobilization and target localization systems for frameless stereotactic cranial and extracranial hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys. 71(1 Suppl):S131–S135. 2008.
Article
25. Tryggestad E, Christian M, Ford E, Kut C, Le Y, Sanguineti G, et al. Inter- and intrafraction patient positioning uncertainties for intracranial radiotherapy: a study of four frameless, thermoplastic mask-based immobilization strategies using daily cone-beam CT. Int J Radiat Oncol Biol Phys. 80:281–290. 2011.
Article
26. Wang CC, Floyd SR, Chang CH, Warnke PC, Chio CC, Kasper EM, et al. Cyberknife hypofractionated stereotactic radiosurgery (HSRS) of resection cavity after excision of large cerebral metastasis: efficacy and safety of an 800 cGy × 3 daily fractions regimen. J Neurooncol. 106:601–610. 2012.
Article